Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2015

View Archived Issues

IMAB-027 safe and well tolerated in first study in humans

Lilly presents clinical data on anti-GCGR MAb for diabetes

First clinical results for nAChR tracer [18F]XTRA

Corbus Pharmaceuticals' Resunab receives FDA orphan drug designation for systemic sclerosis

AnGes reports results of pilot study of Ebola vaccine

DRAM2 mutations linked to retinal dystrophy with early macular degeneration

Cellmid's CAB-102 shown to be safe in toxicology studies

Circadian Technologies receives approval from FDA to initiate trial of OPT-302

Genzyme starts phase I/II trial of olipudase alfa in children with Niemann-Pick disease

PlasmaTech licenses Fanconi anemia gene therapy and CRISPR gene-editing technology

Avalanche Biotechnologies reports phase IIa findings for AVA-101 in wet AMD

U.S. researchers patent new antivirals

Laurent Pharmaceuticals' Lau-7b is safe and well tolerated in patients with cystic fibrosis

Pharmascience describes BTK inhibitors

Universiteit Ghent discloses peloruside analogues

Spanish scientists report vitamin D analogues

Sunshine Lake Pharma develops anti-HBV agents

RedHill Biopharma's RHB-105 meets primary endpoint in phase III H. pylori infection trial

Neovacs launches clinical development program in dermatomyositis

BioBlast initiates phase III study of Cabaletta in oculopharyngeal muscular dystrophy

Atara Biotherapeutics exercises option to T-cell technology from MSK

FDA accepts Teva's BLA for reslizumab in asthma with elevated eosinophil levels

Chiasma files NDA for oral octreotide in acromegaly

Pre-EUA dossier for Cleveland Biolabs' entolimod submitted to FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...